Clinical Trial Update: Mesenchymal Stem Cells Treatment for Decompensated Liver Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for mesenchymal stem cell treatment in decompensated liver cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Liver Cirrhosis

Drugs mentioned

• Mesenchymal stem cells treatment

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Decompensated Liver Cirrhosis | Phase 2 | Status: UNKNOWN